Kohrt, Holbrook E.

Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients

Herbst, R. S., Soria, J.-C., Kowanetz, M., Fine, G. D., Hamid, O., Gordon, M. S., Sosman, J. A., McDermott, D. F., Powderly, J. D., Gettinger, S. N., et al. (2014) · Nature

Cancer Immunotherapy and BiomarkersImmunotherapy and Immune Responses

Cited by 5,231

PD-1 Blockade with pembrolizumab in advanced Merkel-cell carcinoma

Nghiem, P. T., Bhatia, S., Lipson, E. J., Kudchadkar, R. R., Miller, N. J., Annamalai, L., Berry, S., Chartash, E. K., Daud, A., Fling, S. P., et al. (2016) · New England Journal of Medicine

Polyomavirus and related diseasesCancer Immunotherapy and Biomarkers

Cited by 1,258

Results from an integrated safety analysis of urelumab, an agonist anti-CD137 monoclonal antibody

Segal, N. H., Logan, T. F., Hodi, F. S., McDermott, D., Melero, I., Hamid, O., Schmidt, H., Robert, C., Chiarion-Sileni, V., Ascierto, P. A., et al. (2017) · Clinical Cancer Research

Cancer Immunotherapy and BiomarkersImmunotoxicology and immune responses

Cited by 424

Targeting CD137 enhances the efficacy of cetuximab

Kohrt, H. E., Colevas, A. D., Houot, R., Weiskopf, K., Goldstein, M. J., Lund, P., Mueller, A., Sagiv-Barfi, I., Marabelle, A., Lira, R., et al. (2014) · Journal of Clinical Investigation

Immune Cell Function and InteractionMonoclonal and Polyclonal Antibodies Research

Cited by 160

An Ecological?Transactional Model of Significant Risk Factors for Child Psychopathology in Outer Mongolia

Kohrt, H. E., Kohrt, B. A., Waldman, I., Saltzman, K., & Carrion, V. G. (2004) · Child Psychiatry and Human Development

Child and Adolescent Psychosocial and Emotional DevelopmentChild Abuse and Trauma

Cited by 25

CD137 stimulation enhances the vaccinal effect of anti-tumor antibodies

Houot, R., & Kohrt, H. (2014) · OncoImmunology

Immunotherapy and Immune ResponsesCancer Immunotherapy and Biomarkers

Cited by 15